Efficacy of Neuro+ Attention Training
Completed · Not applicable
Conditions studied: ADHD
In brief
This study evaluates the efficacy of the Neuro+ Attention Training System (Neuro+) in improving attention skills in children. Half of participants will receive the Neuro+ intervention for 10 weeks, while the other half will continue treatment as usual (TAU) for the same period. We expect those receiving the Neuro+ intervention to see significant improvements in ADHD symptoms relative to the TAU controls.
Key facts
- Study ID
- NCT02642055
- Run by
- Neuro+
- People needed
- 60
- Starts
- 2015-12-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2016-12-21
Who can join
Age: 8 and older, up to 13. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 8 to 13 at the time of parental informed consent.
- Confirmed ADHD diagnosis at clinic
- No usage of ADHD drugs in past 30 days, or stable on current drug regimen for at least 30 days. Drugs include: Pre specified, oral psychostimulants, including ADDERALL XR® [mixed salts of a single-entity amphetamine product], VYVANSE® [lisdexamfetamine dimesylate], CONCERTA® [methylphenidate HCl], FOCALIN XR® [dexmethylphenidate HCl], RITALIN LA® [methylphenidate HCl extended-release], METADATE CD® [methylphenidate HCl, USP], or other FDA-approved equivalents.
- Ability to follow written and verbal instructions (English)
- Girls or Boys
- Functioning at an age-appropriate level intellectually.
- Ability to comply with all the testing and requirements.
You may not qualify if…
- Current, controlled (requiring a restricted medication) or uncontrolled, comorbid psychiatric diagnosis with significant symptoms such as post-traumatic stress disorder, psychosis, bipolar illness, pervasive developmental disorder, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder, conduct disorder, or other symptomatic manifestations that in the opinion of the Investigator that may confound study data/assessments.
- Motor condition that prevents game playing.
- Recent history (within the past 6 months) of suspected substance abuse or dependence.
- History of seizures (exclusive of febrile seizures), a tic disorder, significant tics, or a current diagnosis of Tourette's Disorder.
- Taken part in a clinical trial within 30 days prior to screening.
- Diagnosis of color blindness.
- Regular use of psychoactive drugs that in the opinion of the Investigator may confound study data/assessments.
- Any other medical condition that in the opinion of the Investigator may confound study data/assessments.
Where it is running
- Neuropsychiatric Clinic at Carolina Partners in Mental HealthCare — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.